OneOncology has partnered with OpenEvidence to integrate AI-powered clinical decision support directly into physician workflows across its national network of community oncology practices. Initially designed to provide rapid access to the latest clinical evidence and research at the point of care, the collaboration is expected to expand to include structured genomic data and clinical trial matching. The partnership reflects the growing adoption of AI as a real-time clinical assistant, helping physicians navigate increasingly complex treatment decisions while accelerating access to precision medicine and evidence-based care.
Keep Reading
Add A Comment